The Senhance System is already approved for pediatric patients in the EU and Japan.
Why Bermuda-Based Insurance Firm James River’s Shares Are Diving Today
James River Group Holdings Ltd (NASDAQ: JRVR) shares are trading lower by around 30% on continued downward momentum after it reported worse-than-expected Q3 FY23 results on Wednesday.